EP4337028A1 - Schlankmachende getränkezusammensetzung - Google Patents
Schlankmachende getränkezusammensetzungInfo
- Publication number
- EP4337028A1 EP4337028A1 EP22728888.3A EP22728888A EP4337028A1 EP 4337028 A1 EP4337028 A1 EP 4337028A1 EP 22728888 A EP22728888 A EP 22728888A EP 4337028 A1 EP4337028 A1 EP 4337028A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- composition
- extract
- relative
- dry weight
- total dry
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 207
- 235000013361 beverage Nutrition 0.000 title description 13
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 claims abstract description 38
- 239000004615 ingredient Substances 0.000 claims abstract description 35
- 235000020733 paullinia cupana extract Nutrition 0.000 claims abstract description 30
- 241000533293 Sesbania emerus Species 0.000 claims abstract description 29
- 239000000284 extract Substances 0.000 claims abstract description 28
- 235000005206 Hibiscus Nutrition 0.000 claims abstract description 27
- 235000007185 Hibiscus lunariifolius Nutrition 0.000 claims abstract description 27
- 235000020688 green tea extract Nutrition 0.000 claims abstract description 26
- 229940094952 green tea extract Drugs 0.000 claims abstract description 25
- 229940069765 bean extract Drugs 0.000 claims abstract description 24
- 150000003839 salts Chemical class 0.000 claims abstract description 18
- 241000218033 Hibiscus Species 0.000 claims description 26
- 238000000034 method Methods 0.000 claims description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 17
- 239000002537 cosmetic Substances 0.000 claims description 14
- 230000001225 therapeutic effect Effects 0.000 claims description 13
- 208000008589 Obesity Diseases 0.000 claims description 11
- 238000004519 manufacturing process Methods 0.000 claims description 11
- 235000020824 obesity Nutrition 0.000 claims description 10
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 9
- 208000035475 disorder Diseases 0.000 claims description 5
- 150000001720 carbohydrates Chemical class 0.000 claims description 4
- 235000014633 carbohydrates Nutrition 0.000 claims description 4
- 201000010099 disease Diseases 0.000 claims description 4
- 239000008194 pharmaceutical composition Substances 0.000 claims description 4
- 208000024172 Cardiovascular disease Diseases 0.000 claims description 3
- 206010028980 Neoplasm Diseases 0.000 claims description 3
- 201000011510 cancer Diseases 0.000 claims description 3
- 201000008482 osteoarthritis Diseases 0.000 claims description 3
- 102000004169 proteins and genes Human genes 0.000 claims description 3
- 108090000623 proteins and genes Proteins 0.000 claims description 3
- 201000002859 sleep apnea Diseases 0.000 claims description 3
- 235000000346 sugar Nutrition 0.000 claims description 3
- 208000032928 Dyslipidaemia Diseases 0.000 claims description 2
- 206010020772 Hypertension Diseases 0.000 claims description 2
- 208000017170 Lipid metabolism disease Diseases 0.000 claims description 2
- 206010036049 Polycystic ovaries Diseases 0.000 claims description 2
- 230000003143 atherosclerotic effect Effects 0.000 claims description 2
- 208000026106 cerebrovascular disease Diseases 0.000 claims description 2
- 201000001883 cholelithiasis Diseases 0.000 claims description 2
- 206010012601 diabetes mellitus Diseases 0.000 claims description 2
- 208000006575 hypertriglyceridemia Diseases 0.000 claims description 2
- 208000000509 infertility Diseases 0.000 claims description 2
- 231100000535 infertility Toxicity 0.000 claims description 2
- 230000036512 infertility Effects 0.000 claims description 2
- 231100000551 menstrual abnormality Toxicity 0.000 claims description 2
- 230000002093 peripheral effect Effects 0.000 claims description 2
- 201000010065 polycystic ovary syndrome Diseases 0.000 claims description 2
- 150000008163 sugars Chemical class 0.000 claims description 2
- 208000011580 syndromic disease Diseases 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 9
- 244000284380 Hibiscus rosa sinensis Species 0.000 abstract 1
- 244000269722 Thea sinensis Species 0.000 description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 6
- 238000000605 extraction Methods 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- 230000004580 weight loss Effects 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 240000003444 Paullinia cupana Species 0.000 description 4
- 235000006468 Thea sinensis Nutrition 0.000 description 4
- XMOCLSLCDHWDHP-IUODEOHRSA-N epi-Gallocatechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@H]2O)=CC(O)=C(O)C(O)=C1 XMOCLSLCDHWDHP-IUODEOHRSA-N 0.000 description 4
- 235000009569 green tea Nutrition 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 150000008442 polyphenolic compounds Chemical class 0.000 description 4
- 235000013824 polyphenols Nutrition 0.000 description 4
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 3
- 235000000556 Paullinia cupana Nutrition 0.000 description 3
- 210000000577 adipose tissue Anatomy 0.000 description 3
- 229960001948 caffeine Drugs 0.000 description 3
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 239000008123 high-intensity sweetener Substances 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 235000013615 non-nutritive sweetener Nutrition 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- PFTAWBLQPZVEMU-ZFWWWQNUSA-N (+)-epicatechin Natural products C1([C@@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-ZFWWWQNUSA-N 0.000 description 2
- WMBWREPUVVBILR-WIYYLYMNSA-N (-)-Epigallocatechin-3-o-gallate Chemical compound O([C@@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=C(O)C=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-WIYYLYMNSA-N 0.000 description 2
- PFTAWBLQPZVEMU-UKRRQHHQSA-N (-)-epicatechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-UKRRQHHQSA-N 0.000 description 2
- LSHVYAFMTMFKBA-TZIWHRDSSA-N (-)-epicatechin-3-O-gallate Chemical compound O([C@@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=CC=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 LSHVYAFMTMFKBA-TZIWHRDSSA-N 0.000 description 2
- YQUVCSBJEUQKSH-UHFFFAOYSA-N 3,4-dihydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C(O)=C1 YQUVCSBJEUQKSH-UHFFFAOYSA-N 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- LSHVYAFMTMFKBA-UHFFFAOYSA-N ECG Natural products C=1C=C(O)C(O)=CC=1C1OC2=CC(O)=CC(O)=C2CC1OC(=O)C1=CC(O)=C(O)C(O)=C1 LSHVYAFMTMFKBA-UHFFFAOYSA-N 0.000 description 2
- WMBWREPUVVBILR-UHFFFAOYSA-N GCG Natural products C=1C(O)=C(O)C(O)=CC=1C1OC2=CC(O)=CC(O)=C2CC1OC(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-UHFFFAOYSA-N 0.000 description 2
- XMOCLSLCDHWDHP-UHFFFAOYSA-N L-Epigallocatechin Natural products OC1CC2=C(O)C=C(O)C=C2OC1C1=CC(O)=C(O)C(O)=C1 XMOCLSLCDHWDHP-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- 239000002535 acidifier Substances 0.000 description 2
- 229940095602 acidifiers Drugs 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 235000020279 black tea Nutrition 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- -1 butanoyl-L-carnitine Chemical compound 0.000 description 2
- LPTRNLNOHUVQMS-UHFFFAOYSA-N epicatechin Natural products Cc1cc(O)cc2OC(C(O)Cc12)c1ccc(O)c(O)c1 LPTRNLNOHUVQMS-UHFFFAOYSA-N 0.000 description 2
- 235000012734 epicatechin Nutrition 0.000 description 2
- DZYNKLUGCOSVKS-UHFFFAOYSA-N epigallocatechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3cc(O)c(O)c(O)c3 DZYNKLUGCOSVKS-UHFFFAOYSA-N 0.000 description 2
- 229940030275 epigallocatechin gallate Drugs 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 235000020333 oolong tea Nutrition 0.000 description 2
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 2
- 235000013616 tea Nutrition 0.000 description 2
- YAPQBXQYLJRXSA-UHFFFAOYSA-N theobromine Chemical compound CN1C(=O)NC(=O)C2=C1N=CN2C YAPQBXQYLJRXSA-UHFFFAOYSA-N 0.000 description 2
- ZFXYFBGIUFBOJW-UHFFFAOYSA-N theophylline Chemical compound O=C1N(C)C(=O)N(C)C2=C1NC=N2 ZFXYFBGIUFBOJW-UHFFFAOYSA-N 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- BWHXEGJOYVNGQH-XOBUMVIESA-N (2s,3r,4s,5r)-2-[(2s,3r,4s,5s,6r)-2-[2-(3,4-dihydroxyphenyl)-5,7-dihydroxychromenylium-3-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]oxyoxane-3,4,5-triol;chloride Chemical compound [Cl-].O([C@@H]1O[C@@H]([C@H]([C@H](O)[C@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)CO1)O)O)CO)C1=CC2=C(O)C=C(O)C=C2[O+]=C1C1=CC=C(O)C(O)=C1 BWHXEGJOYVNGQH-XOBUMVIESA-N 0.000 description 1
- IZLNHYYDCAMWKX-CQSZACIVSA-N (3R)-3-hydroxy-4-oxo-3-[(trimethylazaniumyl)methyl]decanoate Chemical compound C(CCCCCC)(=O)[C@](O)(C[N+](C)(C)C)CC([O-])=O IZLNHYYDCAMWKX-CQSZACIVSA-N 0.000 description 1
- NUFKRGBSZPCGQB-FLBSXDLDSA-N (3s)-3-amino-4-oxo-4-[[(2r)-1-oxo-1-[(2,2,4,4-tetramethylthietan-3-yl)amino]propan-2-yl]amino]butanoic acid;pentahydrate Chemical compound O.O.O.O.O.OC(=O)C[C@H](N)C(=O)N[C@H](C)C(=O)NC1C(C)(C)SC1(C)C.OC(=O)C[C@H](N)C(=O)N[C@H](C)C(=O)NC1C(C)(C)SC1(C)C NUFKRGBSZPCGQB-FLBSXDLDSA-N 0.000 description 1
- WBZFUFAFFUEMEI-UHFFFAOYSA-M Acesulfame k Chemical compound [K+].CC1=CC(=O)[N-]S(=O)(=O)O1 WBZFUFAFFUEMEI-UHFFFAOYSA-M 0.000 description 1
- 239000004377 Alitame Substances 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- OIZFQAFWYYKPMR-PEVLUNPASA-N Delphinidin 3-O-glucoside Natural products O([C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1)C=1[C-](c2cc(O)c(O)c(O)c2)[O+]c2c(c(O)cc(O)c2)C=1 OIZFQAFWYYKPMR-PEVLUNPASA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 239000001329 FEMA 3811 Substances 0.000 description 1
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical class OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 1
- 240000004153 Hibiscus sabdariffa Species 0.000 description 1
- 235000001018 Hibiscus sabdariffa Nutrition 0.000 description 1
- 239000004384 Neotame Substances 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- RDHQFKQIGNGIED-MRVPVSSYSA-N O-acetyl-L-carnitine Chemical compound CC(=O)O[C@H](CC([O-])=O)C[N+](C)(C)C RDHQFKQIGNGIED-MRVPVSSYSA-N 0.000 description 1
- VVPRQWTYSNDTEA-LLVKDONJSA-N O-hexanoyl-L-carnitine Chemical compound CCCCCC(=O)O[C@H](CC([O-])=O)C[N+](C)(C)C VVPRQWTYSNDTEA-LLVKDONJSA-N 0.000 description 1
- CXTATJFJDMJMIY-CYBMUJFWSA-N O-octanoyl-L-carnitine Chemical compound CCCCCCCC(=O)O[C@H](CC([O-])=O)C[N+](C)(C)C CXTATJFJDMJMIY-CYBMUJFWSA-N 0.000 description 1
- UFAHZIUFPNSHSL-MRVPVSSYSA-N O-propanoyl-L-carnitine Chemical compound CCC(=O)O[C@H](CC([O-])=O)C[N+](C)(C)C UFAHZIUFPNSHSL-MRVPVSSYSA-N 0.000 description 1
- VSNFQQXVMPSASB-SNVBAGLBSA-N O-valeroyl-L-carnitine Chemical compound CCCCC(=O)O[C@H](CC([O-])=O)C[N+](C)(C)C VSNFQQXVMPSASB-SNVBAGLBSA-N 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- 239000004376 Sucralose Substances 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 229930003537 Vitamin B3 Natural products 0.000 description 1
- LXNHXLLTXMVWPM-UHFFFAOYSA-N Vitamin B6 Natural products CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 1
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 description 1
- 239000000619 acesulfame-K Substances 0.000 description 1
- 238000005917 acylation reaction Methods 0.000 description 1
- 235000019409 alitame Nutrition 0.000 description 1
- 108010009985 alitame Proteins 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 235000010208 anthocyanin Nutrition 0.000 description 1
- 229930002877 anthocyanin Natural products 0.000 description 1
- 239000004410 anthocyanin Substances 0.000 description 1
- 150000004636 anthocyanins Chemical class 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 1
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 1
- 235000005487 catechin Nutrition 0.000 description 1
- 229950001002 cianidanol Drugs 0.000 description 1
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 1
- RMRCNWBMXRMIRW-BYFNXCQMSA-M cyanocobalamin Chemical compound N#C[Co+]N([C@]1([H])[C@H](CC(N)=O)[C@]\2(CCC(=O)NC[C@H](C)OP(O)(=O)OC3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)C)C/2=C(C)\C([C@H](C/2(C)C)CCC(N)=O)=N\C\2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O RMRCNWBMXRMIRW-BYFNXCQMSA-M 0.000 description 1
- 235000000639 cyanocobalamin Nutrition 0.000 description 1
- 239000011666 cyanocobalamin Substances 0.000 description 1
- 229940109275 cyclamate Drugs 0.000 description 1
- HCAJEUSONLESMK-UHFFFAOYSA-N cyclohexylsulfamic acid Chemical compound OS(=O)(=O)NC1CCCCC1 HCAJEUSONLESMK-UHFFFAOYSA-N 0.000 description 1
- XENHPQQLDPAYIJ-PEVLUNPASA-O delphinidin 3-O-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC2=C(O)C=C(O)C=C2[O+]=C1C1=CC(O)=C(O)C(O)=C1 XENHPQQLDPAYIJ-PEVLUNPASA-O 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 125000004185 ester group Chemical group 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 125000003630 glycyl group Chemical class [H]N([H])C([H])([H])C(*)=O 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 230000005802 health problem Effects 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 238000002803 maceration Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- GXPTVXHTZZVLMQ-GCGJSEPQSA-N myrtillin Natural products O[C@H]1O[C@@H](OCC2=C(OC3=CC(=O)C=C(O)C3=C2)c4cc(O)c(O)c(O)c4)[C@H](O)[C@@H](O)[C@@H]1O GXPTVXHTZZVLMQ-GCGJSEPQSA-N 0.000 description 1
- 239000005445 natural material Substances 0.000 description 1
- ITVGXXMINPYUHD-CUVHLRMHSA-N neohesperidin dihydrochalcone Chemical compound C1=C(O)C(OC)=CC=C1CCC(=O)C(C(=C1)O)=C(O)C=C1O[C@H]1[C@H](O[C@H]2[C@@H]([C@H](O)[C@@H](O)[C@H](C)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 ITVGXXMINPYUHD-CUVHLRMHSA-N 0.000 description 1
- 229940089953 neohesperidin dihydrochalcone Drugs 0.000 description 1
- 235000010434 neohesperidine DC Nutrition 0.000 description 1
- 235000019412 neotame Nutrition 0.000 description 1
- HLIAVLHNDJUHFG-HOTGVXAUSA-N neotame Chemical compound CC(C)(C)CCN[C@@H](CC(O)=O)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 HLIAVLHNDJUHFG-HOTGVXAUSA-N 0.000 description 1
- 108010070257 neotame Proteins 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- DFPAKSUCGFBDDF-UHFFFAOYSA-N nicotinic acid amide Natural products NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 description 1
- 239000011764 pyridoxine hydrochloride Substances 0.000 description 1
- 229960004172 pyridoxine hydrochloride Drugs 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- 239000008247 solid mixture Substances 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 229940075582 sorbic acid Drugs 0.000 description 1
- 235000010199 sorbic acid Nutrition 0.000 description 1
- 239000000021 stimulant Substances 0.000 description 1
- 235000019408 sucralose Nutrition 0.000 description 1
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 description 1
- 150000003892 tartrate salts Chemical class 0.000 description 1
- 229960004559 theobromine Drugs 0.000 description 1
- 229960000278 theophylline Drugs 0.000 description 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011708 vitamin B3 Substances 0.000 description 1
- 235000019160 vitamin B3 Nutrition 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 235000020334 white tea Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
- A23L2/66—Proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Definitions
- the present invention concerns a slimming composition, in particular a slimming cosmetic composition and a slimming pharmaceutical composition, and a beverage comprising said slimming composition.
- the inventors have surprisingly found out that the present invention solves the above-mentioned problems.
- composition (B), herein after] comprising, relative to the total dry weight of the composition (B):
- composition (Be), herein after comprising, relative to the total dry weight of the composition (Be):
- the present invention also concerns a non- therapeutic cosmetic method for improving the aesthetic appearance of a person comprising the administration, preferably the oral administration, to said person of the composition (Be).
- the present invention also concerns a non-therapeutic cosmetic method of slimming care comprising the administration, preferably the oral administration, of the composition (Be).
- the present invention concerns a slimming pharmaceutical composition for use in the therapeutic treatment of obesity or obesity-related disorders [composition (BT), herein after], said composition (BT) comprising, relative to the total dry weight of the composition (BT):
- the present invention also concerns a slimming beverage comprising said composition (B), composition (Be), or composition (BT).
- composition comprising compounds A and B
- the scope of the expression “a composition comprising compounds A and B” should not be limited to compositions consisting only of compounds A and B. It means that with respect to the present invention, the only relevant compounds of the composition are A and B. Accordingly, the terms “comprising” and “including” encompass the more restrictive terms “consisting essentially of” and “consisting of”.
- the terms “slimming beverage” and “slimming composition” are intended to denote respectively a beverage and a composition suitable for inducing a decrease in body weight (e.g., a decrease of 2%, 5%, 10%, 15%, 20%, 25%, 30%, 40%, 50%, 55%, 60%, 70%, 80%, or 90%) and/or a decrease of body dimensions (e.g., measurements of the bust, waist, and/or hips) and/or a decrease in body fat.
- a decrease in body weight e.g., a decrease of 2%, 5%, 10%, 15%, 20%, 25%, 30%, 40%, 50%, 55%, 60%, 70%, 80%, or 90%
- body dimensions e.g., measurements of the bust, waist, and/or hips
- green tea extract is given its usual meaning as known in the art.
- a green tea extract may be a material obtained by at least one solvent (such as water) extraction from Camellia sinensis leaves and/or buds.
- a process for producing green tea extract may also comprise additional steps.
- Camellia sinensis leaves and buds do not undergo the same withering and oxidation processes used to make oolong teas and black teas.
- a green tea extract comprises polyphenols, caffeine and anti-oxidants. Examples of polyphenols present in green tea extracts include but are not limited to: epigallocatechin gallate (EGCG), epigallocatechin (EGC), epicatechin gallate (ECG), epicatechin (EC), and mixtures thereof.
- green coffee bean extract is given its usual meaning as known in the art.
- a green coffee bean extract may be a material obtained by solvent (such as water and/or ethanol and/or any other suitable solvents) extraction from green coffee beans.
- a process for producing green coffee bean extract may also comprise additional steps such as coffee beans grinding.
- green coffee bean refers to either immature coffee beans or even mature coffee beans which have not been roasted.
- Hibiscus extract is given its usual meaning as known in the art.
- a Hibiscus extract may be a material obtained by solvent (such as water and/or ethanol) extraction from Hibiscus flowers, such as Hibiscus sabdariffa flowers.
- a process for producing Hibiscus extract may also comprise additional steps. The extraction is for example often carried out by maceration.
- hibiscus extracts comprise protocatechuic acid and anthocyanins, such as delphinidin-3-O-glucoside, delphinidin-3-O- sambubioside, and cyanidin-3-O-sambubioside and mixtures thereof.
- Guarana extract is given its usual meaning as known in the art.
- a Guarana extract may be a material obtained by solvent (such as water and/or ethanol) extraction from guarana seeds and/or plant.
- a process for producing Guarana extract may also comprise additional steps.
- the guarana plant is also called Paullinia Cupana.
- guarana extracts comprise polyphenols such as catechin and stimulants, such as caffeine, theophylline and theobromine.
- Extracts are usually obtained via solvent extraction which are then concentrated and/or dried.
- extract encompasses a liquid and a solid extract.
- composition (B), as detailed above, may also be in liquid or solid form.
- composition (B), herein after comprising, relative to the total dry weight of the composition (B):
- the composition (B), as detailed above, comprising all these ingredients combined together with guarana extract in the above mentioned weight percentages, has an improved slimming effect. Therefore, the composition (B), as detailed above, is a slimming composition which is suitable for use in non- therapeutic cosmetic methods for improving the aesthetic appearance of a person. Particularly, the composition (B) is a slimming composition which is suitable for use in non-therapeutic cosmetic methods of slimming care.
- said composition (B) comprises, relative to the total dry weight of the composition (B), from 30.00 to 70.00 wt.% of green tea extract and/or green coffee bean extract.
- said composition (B) comprises, relative to the total dry weight of the composition (B), at least 35.00 wt.%, more preferably at least 40.00 wt.%, even more preferably at least 45.00 wt.% of green tea extract and/or green coffee bean extract.
- said composition (B) comprises, relative to the total dry weight of the composition (B), at most 65.00 wt.%, more preferably at most 60.00 wt.%, even more preferably at most 55.00 wt.% of green tea extract and/or green coffee bean extract.
- said composition (B) comprises, relative to the total dry weight of the composition (B), at least 3.00 wt.% and at most 65.00 wt.%, more preferably at least 40.00 wt.% and at most 60.00 wt.%, even more preferably at least 45.00 wt.% and at most 55.00 wt.% of green tea extract and/or green coffee bean extract.
- said composition (B) comprises, relative to the total dry weight of the composition (B), from 10.00 to 40.00 wt. % of Hibiscus extract.
- said composition (B) comprises, relative to the total dry weight of the composition (B), at least 15.00 wt.%, more preferably at least 17.00 wt.%, even more preferably at least 20.00 wt.% of Hibiscus extract.
- said composition (B) comprises, relative to the total dry weight of the composition (B), at most 35.00 wt.%, more preferably at most 30.00 wt.%, even more preferably at most 25.00 wt.% of Hibiscus extract.
- said composition (B) comprises, relative to the total dry weight of the composition (B), at least 15.00 wt.% and at most 35.00 wt.%, more preferably at least 17.00 wt.% and at most 30.00 wt.%, even more preferably at least 20.00 wt.% and at most 25.00 wt.% of Hibiscus extract.
- said composition (B) comprises, relative to the total dry weight of the composition (B), from 0.10 to 10.00 wt. % of guarana extract.
- said composition (B) comprises, relative to the total dry weight of the composition (B), at least 0.50 wt.%, more preferably at least 1 .00 wt.%, even more preferably at least 1 .50 wt.% of guarana extract.
- said composition (B) comprises, relative to the total dry weight of the composition (B), at most 7.00 wt.%, more preferably at most 5.00 wt.%, even more preferably at most 4.00 wt.% of guarana extract.
- said composition (B) comprises, relative to the total dry weight of the composition (B), at least 0.50 wt.% and at most 7.00 wt.%, more preferably at least 1 .00 wt.% and at most 5 wt.%, even more preferably at least 0.25 wt.% and at most 4.00 wt.% of guarana extract.
- said composition (B) comprises, relative to the total dry weight of the composition (B), from 10.00 to 40.00 wt. % of said at least one fat burning ingredient.
- said composition (B) comprises, relative to the total dry weight of the composition (B), at least 15.00 wt.%, more preferably at least 17.00 wt.%, even more preferably at least 20.00 wt.% of said at least one fat burning ingredient.
- said composition (B) comprises, relative to the total dry weight of the composition (B), at most 35.00 wt.%, more preferably at most 30.00 wt.%, even more preferably at most 28.00 wt.% of said at least one fat burning ingredient.
- said composition (B) comprises, relative to the total dry weight of the composition (B), at least 15.00 wt.% and at most 35.00 wt.%, more preferably at least 17.00 wt.% and at most 30.00 wt.%, even more preferably at least 20.00 wt.% and at most 28.00 wt.% of said at least one fat burning ingredient.
- said at least one fat burning ingredient is chosen among L-carnitine, alkanoylated L-carnitine, or salts thereof.
- alkanoylated L-carnitine is intended to denote L-carnitine wherein the hydroxyl group has undergone an acylation reaction, thereby resulting in the formation of an ester group.
- the alkanoylated L-carnitine may be any alkanoylated L-carnitine known by the skilled in the art.
- alkanoylated L-carnitine examples include but are not limited to: acetyl-L-carnitine, propionyl-L-carnitine, butanoyl-L-carnitine, pentanoyl-L- carnitine, hexanoyl-L-carnitine, heptanoyl-L-carnitine, octanoyl-L-carnitine.
- Salts of L-carnitine or alkanoylated L-carnitine can be any suitable salt known by the skilled in the art.
- salts include but are not limited to: mucate salt, tartrate salt, fumarate salt, glycine salt.
- said at least one fat burning ingredient is L-carnitine.
- said composition (B) comprises, relative to the total dry weight of the composition (B): - from 45.00 to 55.00 wt.% of green tea extract and/or green coffee bean extract;
- said composition (B) has an energy content of at most 20 kJ, more preferably at most 15 kJ, even more preferably at most 11 kJ.
- said composition (B) comprises, relative to the total dry weight of said composition (B), at most 0.50 wt.%, more preferably at most 0.25 wt.%, even more preferably at most 0.10 wt.% of carbohydrate such as sugars.
- said composition (B) is free of carbohydrates.
- said composition (B) comprises, relative to the total dry weight of said composition (B), at most 0.50 wt.%, more preferably at most 0.25 wt.%, even more preferably at most 0.10 wt.% of proteins.
- composition (B) is free of proteins.
- said composition (B) comprises, relative to the total dry weight of said composition (B), at most 0.50 wt.%, more preferably at most 0.25 wt.%, even more preferably at most 0.10 wt.% of fat.
- said composition (B) is free of fat.
- composition (B) may comprise additional ingredients such as acidifiers, high intensity sweeteners, flavors and vitamins and mixtures thereof.
- Suitable acidifiers include but are not limited to citric acid, phosphoric acid, sorbic acid and mixtures thereof.
- High intensity sweeteners are defined as synthetic or natural substances which have no or almost no calories and a sweetness potency several times higher than sugar.
- suitable high intensity sweeteners include but are not limited to sucralose, acesulfame K, stevia glycoside, alitame, aspartame, cyclamate, neohesperidin dihydrochalcone, neotame, saccharin and mixtures thereof.
- vitamins include but are not limited to: vitamin C, vitamin B6, vitamin B12, vitamin B3 and mixtures thereof.
- composition (B) according to the present invention may comprise vitamin C, nicotinamide, calcium-D-pantothenate, cyanocobalamine, pyridoxine hydrochloride.
- Said composition (B) may be liquid or solid.
- composition (B) may be a slimming beverage composition.
- the composition (B) may thus additionally comprise water.
- said composition (B) comprises, relative to the total weight of said composition (B), at least 90.00 wt.%, more preferably at least 95.00 wt.%, even more preferably at least 98.00 wt.% of water.
- said composition (B) comprises, relative to the total weight of said composition (B), at most 99.99 wt.%, more preferably at most 99.95 wt.% of water.
- said composition (B) comprises, relative to the total weight of said composition (B), at least 90.00 wt.% and at most 99.99 wt.%, more preferably at least 95.00 wt.% and at most 99.99 wt.%, even more preferably at least 98.00 wt.% and at most 99.95 wt.% of water.
- said composition (B) is a solid composition, preferably said composition (B) is a powdered composition.
- composition (Be), herein after comprising, relative to the total dry weight of the composition (Be):
- composition (B) from 10.00 to 40.00 wt. % of at least one fat burning ingredient chosen among L-carnitine, alkanoylated L-carnitine, or salts thereof.
- All the definitions, preferences and preferred embodiments of the composition (B) according to the invention also apply mutatis mutandis to the composition (Be).
- the composition (Be) is a slimming composition which is suitable for use in non-therapeutic cosmetic methods for improving the aesthetic appearance of a person.
- the composition (Be) is a slimming composition which is suitable for use in non-therapeutic cosmetic methods of slimming care.
- the inventors have now surprisingly found that, as a consequence of a synergy between the constituting ingredients as comprised within the composition (Be), as detailed above, the improved slimming effect of the composition (Be) is more important than the sum of the slimming effects caused by each of the ingredients of said composition (Be). This result is all the more surprising given the small amount of guarana extract comprised in the composition (Be).
- the present invention also concerns a non- therapeutic cosmetic method for improving the aesthetic appearance of a person comprising the administration, preferably the oral administration, to said person of the composition (Be).
- the present invention also concerns a non-therapeutic cosmetic method of slimming care comprising the administration, preferably the oral administration, of the composition (Be).
- composition (BT), herein after a slimming pharmaceutical composition for use in the therapeutic treatment of obesity and obesity-related disorders [composition (BT), herein after], said composition (BT) comprising, relative to the total dry weight of the composition (BT):
- composition (B) according to the invention also apply mutatis mutandis to the composition (BT).
- Non-limiting examples of obesity-related disorders notably include: dyslipidemia, hypertriglyceridemia, hypertension, diabetes, Syndrome X, atherosclerotic disease, cardiovascular disease, cerebrovascular disease, peripheral vessel disease, cholesterol gallstones, cancer, menstrual abnormalities, infertility, polycystic ovaries, osteoarthritis, and sleep apnea.
- composition (BT) is generally administered to a subject in therapeutically effective amounts.
- composition (BT) is orally administered to a subject in therapeutically effective amounts.
- the method for producing said composition (B) may comprise the following step:
- said method further comprises the following step:
- said contacting step (ii) contacting the first mixture obtained by said contacting step (i) with water. More preferably, said contacting step (ii) may comprise at least partial dissolution of said green tea extract and/or green coffee bean extract and said Hibiscus extract and said guarana extract and said at least one fat burning ingredient in water.
- said method for producing said composition (B) may comprise adding in water: from 30.00 to 70.00 wt. % of green tea extract and/or green coffee bean extract; from 10.00 to 40.00 wt. % of Hibiscus extract; from 0.10 to 10.00 wt. % of guarana extract; and from 10.00 to 40.00 wt. % of at least one fat burning ingredient chosen among L-carnitine, alkanoylated L-carnitine, or salts thereof, relative to the total dry weight of said composition (B).
- composition (B) according to the invention also apply to the method for producing said composition (B).
- the present invention concerns a method for producing the composition (Be), as detailed above.
- the present invention concerns a method for producing the composition (BT), as detailed above.
- Example 1 A composition (B) was prepared by mixing different ingredients shown in table 1 together. The content of the composition (B) is shown in table 1 .
- composition (B) was dissolved in water. 1 g of composition (B) was dissolved in 250 ml_ of water.
- composition (B) further comprised the ingredients shown in table
- the obtained slimming beverage was consumed by several people. It was observed that there is a synergy between the guarana extract and the other ingredients of the composition (B). As a result, the improved slimming effect of composition (B) is more important than the sum of the slimming effects caused by each of the ingredients of the composition (B).
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Hematology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Botany (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Child & Adolescent Psychology (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP21173694 | 2021-05-12 | ||
PCT/EP2022/062993 WO2022238558A1 (en) | 2021-05-12 | 2022-05-12 | Slimming beverage composition |
Publications (1)
Publication Number | Publication Date |
---|---|
EP4337028A1 true EP4337028A1 (de) | 2024-03-20 |
Family
ID=75936687
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP22728888.3A Pending EP4337028A1 (de) | 2021-05-12 | 2022-05-12 | Schlankmachende getränkezusammensetzung |
Country Status (2)
Country | Link |
---|---|
EP (1) | EP4337028A1 (de) |
WO (1) | WO2022238558A1 (de) |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005034650A1 (en) * | 2003-10-17 | 2005-04-21 | Diet Formulations Ltd. | Weight-loss supplement |
PL395070A1 (pl) * | 2011-05-31 | 2012-12-03 | Kazub Bogdan | Herbata odchudzajaca |
US9220753B1 (en) * | 2015-06-24 | 2015-12-29 | Juan Carlos Musi | Product for losing weight |
US20180133188A1 (en) * | 2016-11-14 | 2018-05-17 | Jordan McKinnon | Weight-loss beverage composition and method |
-
2022
- 2022-05-12 WO PCT/EP2022/062993 patent/WO2022238558A1/en active Application Filing
- 2022-05-12 EP EP22728888.3A patent/EP4337028A1/de active Pending
Also Published As
Publication number | Publication date |
---|---|
WO2022238558A1 (en) | 2022-11-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2532332C (en) | Dietary supplement for promoting control of blood-sugar levels and associated pathology in type 2 diabetics | |
TWI492715B (zh) | Containing polymerized catechins | |
CA2658905A1 (en) | Improved beverage | |
US20090047405A1 (en) | Food composition with therapeutic agents | |
CA2632067C (en) | Method for improving absorbability of epigallocatechin gallate, foods, drinks and food/drink materials using the same and method for producing the same | |
EP2303297B1 (de) | Wasserlösliche extrakte von artemisia dracunculus (estragon) zur verbesserung des glucosestoffwechsels | |
KR20160144791A (ko) | 여성 갱년기 증상 개선용 조성물 | |
KR101770606B1 (ko) | 황련 및 펠라고니움 시도이데스 혼합 추출물을 유효성분으로 포함하는, 진해 거담용 조성물 | |
JP5027502B2 (ja) | 骨粗鬆症予防または治療剤 | |
JP6821163B2 (ja) | ゴシュユ抽出物又はエボジアミンを有効成分として含むカフェイン中毒による疾患の予防又は治療用組成物 | |
JP5576694B2 (ja) | Gip上昇抑制剤 | |
US20080311252A1 (en) | Chocolate based dietary supplement product or sweet beverage product | |
EP2756765B1 (de) | Pharmazeutische Zubereitungen | |
JP2013169204A (ja) | 砂糖代替甘味料 | |
EP4337028A1 (de) | Schlankmachende getränkezusammensetzung | |
JP3130327B2 (ja) | 肝機能障害予防剤及び肝機能障害予防作用を有する機能性食品 | |
JP3863482B2 (ja) | インスタント粉末飲料 | |
KR20220046736A (ko) | 구절초 및 꾸지뽕 복합 추출물을 유효성분으로 포함하는 항염증 조성물 | |
JP3481246B2 (ja) | 苦・渋味増強法 | |
KR20020033452A (ko) | 항비만 녹차 및 그의 제조방법 | |
KR102010858B1 (ko) | 콩발아배아 추출물을 포함하는 숙취의 예방 또는 치료용 조성물 | |
CN117794393A (zh) | 口服组合物 | |
JP4451690B2 (ja) | 飲食品組成物 | |
JP6234838B2 (ja) | 飲料 | |
KR20210150867A (ko) | 팥순 추출물을 포함하는 골다공증 예방 또는 치료용 조성물 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: UNKNOWN |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20231211 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
DAV | Request for validation of the european patent (deleted) | ||
DAX | Request for extension of the european patent (deleted) |